Mahamaya Lifesciences Limited
BBSE:MAHALIFEShare Statistics
As of June 30, 2025, Mahamaya Lifesciences Limited has 23.41M shares outstanding.
| Shares Outstanding | 23.41M |
Financial Position
As of June 30, 2025, Mahamaya Lifesciences Limited maintains a current ratio of 1.18, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.18 |
| Quick Ratio | 0.03 |
| Debt / Equity | 107.88 |
Taxes
INROver the twelve months ended June 30, 2025, Mahamaya Lifesciences Limited recorded 15.87M in income tax expense.
| Income Tax | 15.87M |
Stock Price Statistics
INRThese figures are as of the close on October 22, 2026. The 50-day moving average sits at 182.62, while the 200-day moving average is 175.09.
| 50-Day Moving Average | 182.62 |
| 200-Day Moving Average | 175.09 |
Balance Sheet
INRAs of June 30, 2025, Mahamaya Lifesciences Limited holds 41.97M in cash and equivalents against 577.15M in total debt, resulting in a net debt position of 570.29M. Total book value stands at 534.97M, with working capital of 291.46M providing operational flexibility.
| Cash & Cash Equivalents | 41.97M |
| Total Debt | 577.15M |
| Net Debt | 570.29M |
| Equity (Book Value) | 534.97M |
| Book Value Per Share | 22.86 |
| Working Capital | 291.46M |
Cash Flow
INRThese figures cover the twelve months ended June 30, 2025.
| Capital Expenditures | -2.81M |